Navigation Links
Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Date:8/19/2007

Company on Target to File Supplemental New Drug Application in the Fourth

Quarter

FRAZER, Pa., Aug. 16 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced positive results from a 12-week, Phase 3 clinical trial of FENTORA(R) (fentanyl buccal tablet) [C-II] in patients with breakthrough pain associated with a broad range of chronic non-cancer pain conditions. The study achieved statistical significance on the primary endpoint. Results across the 12 weeks of treatment showed both statistically significant and clinically relevant outcomes for patients with breakthrough pain who were already receiving and who were tolerant to opioid therapy for their underlying persistent pain. FENTORA is approved only for the management of breakthrough pain in patients with cancer who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

"We are excited to complete our Phase 3 program with this third and final controlled study. These data show similar positive outcomes as those with FENTORA in treating breakthrough pain in opioid-tolerant patients with cancer, chronic neuropathic pain, and chronic low-back pain," said Dr. Lesley Russell, Executive Vice President, Worldwide Medical and Regulatory Operations. "We plan to submit these data to the Food and Drug Administration in the fourth quarter as part of our supplemental New Drug Application."

About the Study

The double-blind, placebo-controlled, variable dose Phase 3 trial included 148 patients. The primary endpoint was the Sum of Pain Intensity Differences from five to 60 minutes (SPID(60)) as assessed after 12 weeks of treatment. SPID(60) is a measure that assesses analgesic efficacy of a pain medication over the first 60 minutes after treatment. Patients treated with FENTORA showed a statistically significant improvement on the primary endpoint (p<0.0001) compared with placebo. FENTORA was general
'/>"/>

SOURCE Cephalon, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 Food and ... increasingly searching for food alternatives that offer variety, ... The food ingredient market has numerous players operating ... as Vital Force Technology (VFT). VFT is ... 4,000 energetic patterns, all tested to produce stable, ...
(Date:7/31/2014)... Texas (PRWEB) August 01, 2014 ... and China Polyurethane Resin Industry” is a ... Resin market. The report introduces Polyurethane Resin ... and industry chain structure and industry overview. ... including China’s domestic market as well as ...
(Date:7/31/2014)... 31, 2014 Today BioSpace , the leading life sciences ... campaign spotlighting the life sciences community in Illinois , ... Kansas , Michigan , Minnesota ... Ohio and Wisconsin . ... of all job postings on BioSpace originating in this region in 2013. ...
(Date:7/31/2014)... 31, 2014 Nearly 20,000 medical professionals and ... Meeting & Clinical Lab Expo in Chicago ... breakthroughs in diagnostic research and technology that will advance ... As of Wednesday, July 30, more than 19,500 ... & Clinical Lab Expo, with more than 10,000 of ...
Breaking Biology Technology:Functional Ingredient Manufacturer – Vital Force Technology Infuses Raw Materials & Ingredients with Subtle Energy Formula 2Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 2Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 3Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 4Midwest Biotech Leaders Featured On BioSpace Map 2Research on Digital Health, Alzheimer's, Ebola Draws Nearly 20,000 Attendees to 2014 AACC Annual Meeting & Clinical Lab Expo 2Research on Digital Health, Alzheimer's, Ebola Draws Nearly 20,000 Attendees to 2014 AACC Annual Meeting & Clinical Lab Expo 3
... start-up, CEOs, business development executives, and service providers from ... ... the globe, MASSAPEQUA, N.Y. and CLEVELAND, April 11 ... Corporation, the Cleveland-based bioscience business,formation, recruitment, and acceleration initiative, are ...
... STREAM, N.Y., April 11 Powersafe,Technology Corp. (OTC ... with Amplification Technologies, Inc., a privately held Delaware,corporation. ... Amplification,will merge with a wholly-owned subsidiary of Powersafe ... be newly issued to,shareholders of Amplification and reserved ...
... NEWS, Va., April 11 Dilon Technologies, Inc., ... today that nine additional Dilon 6800 orders have ... first quarter., The Dilon 6800, a high-resolution, ... Imaging (BSGI), a molecular,breast imaging technique used for ...
Cached Biology Technology:IBF Conferences Inc*International Business Forum and BioEnterprise Corporation present the 2nd Annual Global Healthcare Investing Conference 2IBF Conferences Inc*International Business Forum and BioEnterprise Corporation present the 2nd Annual Global Healthcare Investing Conference 3Powersafe Technology Corp. Recapitalizes, Executes Merger Agreement with Amplification Technologies, and Invests in Amplification 2
(Date:8/1/2014)... of a new study, including two Simon Fraser ... industry representatives and policymakers must collaborate closely on ... gas development. Viorel Popescu and Maureen Ryan, David ... Sciences department, are among eight international co-authors of ... Ecology and the Environment . , Shale gas ...
(Date:7/31/2014)... from shale rock has increased by more than ... not fully understand the industry,s effects on nature ... journal Frontiers in Ecology and the Environment ... outpace scientific examination, a team of eight conservation ... University, concluded that determining the environmental impact of ...
(Date:7/31/2014)... to be a key gene responsible for hearing in mammals. ... of the inner ear that contracts and expands rapidly to ... horn, amplify sound waves to make hearing more sensitivity. ... online edition of Molecular Biology and Evolution , Peng ... evolved to play a critical role in the ultrasonic hearing ...
Breaking Biology News(10 mins):Scientists warn time to stop drilling in the dark 2Scientists warn time to stop drilling in the dark 3'Fracking' in the dark: Biological fallout of shale-gas production still largely unknown 2'Fracking' in the dark: Biological fallout of shale-gas production still largely unknown 3
... studies by researchers at UT Southwestern Medical Center sheds light ... immune defenses and may aid in the development of more ... as well as the flu and the common cold. , ... the Journal of Virology and currently available online, UT Southwestern ...
... team of scientists has used gene therapy in two ... movements in monkeys and rats with a drug-induced form ... the scientific publications Brain and The Journal of Neuroscience, ... its onset and another strategy to treat the devastating ...
... last week reveal how an,evolutionary innovation involving the ... rise to a deep-seated dependency between them for ... how genetic exchange through interbreeding,between two species can ... a,high level of biological organization - in this ...
Cached Biology News:Studies reveal methods viruses use to sidestep immune system 2Studies reveal methods viruses use to sidestep immune system 3Gene Therapy For Parkinson's Disease Moves Forward In Animals 2Gene Therapy For Parkinson's Disease Moves Forward In Animals 3Gene Therapy For Parkinson's Disease Moves Forward In Animals 4Ants Genetic Engineering Leads To Species Interdependency 2
... ultra high yield technology is fast - ... aRNA for gene array analysis ... , Kits specific for templates with ... , All kits contain SUPERaseIn ...
Rad 51C Immunogen: His-tagged human Rad 51C, over-expressed in E. coli Storage: 4 C...
...
...
Biology Products: